dc.contributor.author |
Enck, Paul |
|
dc.contributor.author |
Klosterhalfen, Sibylle |
|
dc.date.accessioned |
2022-04-04T07:02:32Z |
|
dc.date.available |
2022-04-04T07:02:32Z |
|
dc.date.issued |
2021 |
|
dc.identifier.issn |
1663-9812 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/125919 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Frontiers Media Sa |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.3389/fphar.2021.641436 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20210512015105_00238 |
|
utue.personen.roh |
Enck, Paul |
|
utue.personen.roh |
Klosterhalfen, Sibylle |
|
dcterms.isPartOf.ZSTitelID |
Frontiers in Pharmacology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 641436 |
de_DE |
dcterms.isPartOf.ZS-Volume |
12 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |